KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) EBT Margin (2016 - 2025)

Historic EBT Margin for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to 42.85%.

  • Eli Lilly's EBT Margin rose 56200.0% to 42.85% in Q4 2025 from the same period last year, while for Dec 2025 it was 39.48%, marking a year-over-year increase of 113300.0%. This contributed to the annual value of 39.48% for FY2025, which is 113300.0% up from last year.
  • Latest data reveals that Eli Lilly reported EBT Margin of 42.85% as of Q4 2025, which was up 56200.0% from 41.09% recorded in Q3 2025.
  • Over the past 5 years, Eli Lilly's EBT Margin peaked at 43.56% during Q2 2025, and registered a low of 4.5% during Q3 2023.
  • In the last 5 years, Eli Lilly's EBT Margin had a median value of 25.71% in 2022 and averaged 26.27%.
  • In the last 5 years, Eli Lilly's EBT Margin plummeted by -180500bps in 2023 and then skyrocketed by 272100bps in 2025.
  • Eli Lilly's EBT Margin (Quarter) stood at 23.0% in 2021, then rose by 25bps to 28.71% in 2022, then decreased by -7bps to 26.82% in 2023, then surged by 39bps to 37.23% in 2024, then grew by 15bps to 42.85% in 2025.
  • Its last three reported values are 42.85% in Q4 2025, 41.09% for Q3 2025, and 43.56% during Q2 2025.